CYTK — CYTOKINETICS INC

Ownership history in Advisory Services Network, LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in CYTOKINETICS INC (CYTK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2024 Q4)
Avg. % of fund
0.0%
First filed
2020 Q3
Last filed
2025 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 574 -5,165 -90.0% 0.00% $32K $54.96
2024 Q4 ADDED 5,739 +4,789 +504.1% 0.01% $270K $47.04
2023 Q4 REDUCED 950 -400 -29.6% 0.00% $79K $83.49
2023 Q1 UNCHANGED 1,350 — 0% 0.00% $48K $35.19
2022 Q4 ADDED 1,350 +1,200 +800.0% 0.00% $62K $45.82
2021 Q2 UNCHANGED 150 — 0% 0.00% $3K $19.79
2020 Q4 UNCHANGED 150 — 0% 0.00% $3K $20.78
2020 Q3 INITIATED 150 — — 0.00% $3K $21.65
% of Fund (quarterly)    CYTK price (monthly, adj. close)

Other funds also holding CYTK

As of 2025 Q4 — sorted by position size

Foresite Capital Management IV, LLC 3Y 7Y 12.68% Sarissa Capital Management LP 3Y 7Y 11.3% DAFNA Capital Management LLC 3Y 7Y 5.48% Integral Health Asset Management, LLC 3Y 4.42% Rosalind Advisors, Inc. 4.36% Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 4.22% Melqart Asset Management (UK) Ltd 3Y 7Y 3.9% Exome Asset Management LLC 3.79% Deep Track Capital, LP 3Y 3.78% Checkpoint Capital L.P. 3.31%
← Back to Advisory Services Network, LLC Holdings